pure retatrutide Buy 15mg / $140 only Retatrutide Europe - RUO Research

Back in 2018, most of its earnings came from generics, with only a small share driven by innovation. Between 2025 and 2027, the company expects to bring dozens of major breakthroughs to market from GLP-1 therapies for obesity and diabetes to next-generation oncology treatments. Source: *Opinions are my own To view or add a comment, sign in Big Pharma News: Pfizer is set to acquire Metsera in a deal worth up to $4.9B Why it matters: $47.50/share upfront + $22.50/share tied to milestones Lead candidate MET-097i (GLP-1 therapy) showed 11.3% weight loss in 12 weeks Pipeline includes monthly amylin-based injections + oral obesity drugs Puts Pfizer head-to-head with Lilly & Novo Nordisk in the obesity race This move highlights the booming obesity drug market and pharmas growing appetite for metabolic innovation

The FDA does not evaluate compounded drug products for safety, effectiveness, or quality. The ad did not include verbal recognition of the fact its drugs are compounded or not FDA approved

Lukewarm Glutathione 1K Orange Flavour Effervescent with Lukewarm Vitamin C with Zinc Effervescent Effervescent Formulas: Convenience Meets Science While traditional capsules and tablets are common, effervescent supplements dissolve quickly in water for a pleasant, easy-to-consume beverage

These were measured at baseline and weekly for 10 weeks (on Days 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70)